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Thomas H. Lee, MD, MSc, interviews Tarek Elsawy, MD, President and CEO of Reliant Medical Group and Regional President of OptumCare.

*This conversation is an editorial feature, fully independent of Optum's partnership with* NEJM Catalyst Innovations in Care Delivery.

Tom Lee:

This is Tom Lee, the Editor-in-Chief of NEJM Catalyst, talking with Tarek Elsawy, who is a physician and President and CEO of Reliant Medical Group in the Worcester, Massachusetts area, and Regional President for OptumCare. In that role, he leads a large group of physicians, making the journey from whatever their structure was in the past toward something approaching a single organization trying to push higher-value care. That's what we're talking with him about today. That journey has been accelerated by the Covid-19 pandemic, as I think everyone here knows. It's worth noting that this conversation is an editorial feature, fully independent of Optum's partnership with *NEJM Catalyst Innovations in Care Delivery*. It was set in process because I think Tarek is one of the best young leaders in health care today.

Tarek Elsawy:

Tom, it's a pleasure to be here. Thank you for having me.

Lee:

Tarek, why don't you start by telling our listeners a bit about Optum and the physician organizations that you are leading?

Elsawy:

OptumHealth is probably one of the larger organizations in health care that a lot of people don't know that much about. We are one of the three pillars of Optum, which are OptumHealth, the care delivery arm, Optum Analytics, the data arm, and OptumRx, which deals with pharmacy benefits. At OptumHealth, \[one of\] its major components is OptumCare, which is where I work. I'm the Regional President of OptumCare, which comprises about 27 different medical groups, our surgical care affiliates, and MedExpress, which is our urgent care compartment.

We touch about 18 million patients across 44 states, and we have about 52,000 aligned physicians, 12,000 advanced practice clinicians. We also have the behavioral health section, care services section, a population health segment, medical benefits management, and a consumer engagement section. We're a broad organization that touches health care in many different ways.

Lee:

I expect that your doctors didn't just come out of medical school and sign up to become employed doctors of Optum. They must have come to it from many directions and a variety of business contexts. My guess is that many of them are still figuring out that they're part of a bigger organization. Can you give a us a feel for where they came from and how heterogenous the organization is?

"We can be safer and we can be more reliable, but the major issues relate to access, affordability, health care inequity, provider well-being, wasteful spending."

Elsawy:

Absolutely. We look like the rest of the country, Tom. Our doctors come from organizations, \[some of which\] are heavily steeped in fee-for-service, or all they do is fee-for-service, and we have others that are fully engaged in risk-based care or value-based care in all lines, whether it's commercial risk, Medicare risk, Medicaid risk. They come from so many different places. The vast majority have occurred through acquisitions. The organization is only 12 years old, but the evolution and the purpose is clear: Our intent is to become as much of a value-based organization as we possibly can.

The reality is, if you listen to most people, it's not \[so much\] that they complain about the quality of care in the U.S. Yes, for sure, we can be safer and we can be more reliable, but the major issues relate to access, affordability, health care inequity, provider well-being, wasteful spending --- all the things that we've been talking about. But we are convinced, or at least I am convinced, that the way that we're going to get there is to further align our payment methodology and incentivize fixing those things, because if we haven't learned anything \[else\] from Covid-19, there are so many parts of the fee-for-service system that are broken. This allows us to align it in a much more complete way.

Lee:

You brought up Covid-19, and I don't think any conversation in health care these days can go more than a few minutes without Covid-19 coming up naturally. My guess is that Covid-19 affected the entire network of physicians that you work with dramatically. It might be the first common big influence that they all really felt. How did Covid-19 play out for the physicians in your region?

Elsawy:

As I think about the impact of Covid-19, it's been multifaceted. There is the impact you feel as a person living in the U.S. right now, and then trying to navigate as a physician and as part of an organization. As I look at it organizationally, or at the big picture, there are so many clear-cut learnings, but it has really highlighted a lot of the flaws and the strengths. When I think about our public health system, \[which\] has some of the most brilliant and dedicated people working in it, it's become clear: We need to significantly fortify and strengthen their infrastructure. The flaws, when you're talking about how our providers felt it, there was an incredible difference in how providers who are in a pure fee-for-service environment were devastated by the impact of Covid-19. I suspect that's going to be continuing, because I don't think this is a one-and-done phenomena, as we're seeing throughout the country.

We are seeing that what we've been doing in behavioral health and post-acute care isn't enough. We need to do more. It's taken a pandemic to finally make folks see the value of telehealth in a meaningful way and having better digital platforms, but we've also discovered it that was more clunky than we thought, even though we had incredible rapid adoption. A lot of the folks who needed it, we couldn't get it to them efficiently enough.

Those were some global learnings. Organizationally, I was incredibly proud of how Optum and UHG \[UnitedHealth Group\] as a whole handled it. We were able to navigate it without layoffs, without furloughs, and the organization took some extraordinary efforts to make our providers and patients feel safe during this time period, which was absolutely critical. One of the things that you are always learning: We saw some data in our most recent surveys \[which showed that\] patient experience scores for many of our organizations that were flat or plateaued all took extraordinary jumps because the patients noticed the effort that was going in into making them safer, and us being more accessible to them.

"I don't think this \[pandemic\] is a one-and-done phenomena, as we're seeing throughout the country."

In terms of managing and meeting things, I need to do a better job going forward of making sure that \[we\] remove barriers from people, because when the decision-making barriers are removed, \[it's\] remarkable how much more nimble we become and how much more creative folks become. That is a lesson, clearly, I want to make sure that we hold onto and that I don't fall back into business as usual.

I don't know that I've ever been prouder to be a physician. I'm in awe of some of my colleagues; they have done remarkable work. It has really highlighted the fact that we were able to refocus on purpose and meaning in what we do every day.

So, a lot of good things, a lot of bad things, but overall, if we can focus in on capturing the opportunities coming out of Covid-19, it'll be pretty remarkable.

Lee:

It sounds like some groups were in more financial risk than others, and those groups were less injured, financially, by the changes that occurred with Covid-19. The ones that were pure fee-for-service probably took an enormous hit, but you've painted the picture of an optimist, and you and I are similarly optimistic in that our colleagues did a lot to make themselves proud. It also sounds like a lot happened to make them glad that they were part of a bigger organization that could help them respond to the need to do telemedicine well, for example. Whatever ambivalence there might have been to being part of a bigger organization before Covid-19, it's probably less today than it was in 2019?

Elsawy:

I totally agree with you. One of the difficult things, regardless of where you are, if you're in a large organization --- whether it's at a large academic medical center or an organization like Optum or UnitedHealth Group --- there is always this fear that you're going to lose the battle for the hearts and minds of providers and patients. It's responses like this, in a time of crisis, that let you know a lot more about the organization than you otherwise would. People show their true colors when the chips are down. \[But\] the decisions that were made \[were\] earned. At least for me, I have some degree of skepticism about how an organization is going to behave, but I honestly could not have been prouder.

Lee:

In a perverse way, in an unfortunate, but fortunate at the same time way, Covid-19 creates opportunities for you, and that makes me want to throw out a question to wind up our conversation. Tell us, what are you hoping that your groups are going to look like in 5 years?

Elsawy:

These are ambitious, but we have to be ambitious now. This is one of those things that also makes you come out of this Covid-19 environment thinking, I need to think bigger. I'm hoping that all of us think bigger, and while these are ambitious, I don't think these are undoable.

"It's responses like this, in a time of crisis, that let you know a lot more about the organization than you otherwise would."

One, I would like us to become the prominent physician-led, ambulatory, value-based health care system in the country because we need to scale to solve some of the issues. We have scale, and we're going to hopefully continue to grow. We need to get to the point where we're delivering great care, but also at a cost that we can afford. Unless you have enough scale to influence the system as a whole, that would be difficult to do. So being the prominent value-based care organization in the ambulatory setting is one goal.

\[Another\] goal needs to be one of the leading organizations engaged in health care delivery research. We're fairly uniquely suited, given the scale and access to data, and we have wonderful partners, OptumLabs and UnitedHealth Group R&D and already many academic institutions, so I would like to see us develop a true footprint in that space.

I also would love to see us become the destination of choice for clinicians, whether they're in primary care or in specialty care, who are passionate about value-based care, because there needs to be a degree of passion and a singular focus to do that.

I would say, lastly, \[that\] we need to get a lot better about actually meeting patients' preferences on how care is delivered. We need to be a lot more personalized and become truly consumer centered. If we accomplish those ambitious goals, not only will we as an organization be better off, but honestly, we will be part of the solution for the country as a whole.

Lee:

That's a good set of goals. You were pushing for an organization that delivers high-value care, which means getting efficient, as well as effective at doing things; one that's innovative, advancing science and what we know about health care delivery; one that addresses burnout, resilience, and makes practicing medicine a great thing to do; and then one that's patient centered. Good aspirations for all of us. We are rooting for your success, and I hope you'll be putting pressure on the rest of health care to keep up.

Elsawy:

Thank you, Tom. We won't stop. We appreciate the opportunity to talk to you about it.

**Disclosures:** Tarek Elsawy is President and CEO of Reliant Medical Group and Regional President of OptumCare. This conversation is independent of Optum's partnership with *NEJM Catalyst Innovations in Care Delivery*. Thomas H. Lee is CMO of Press Ganey and Editor-in-Chief of *NEJM Catalyst Innovations in Care Delivery*.
